楊順發Shun-Fa Yang洪雲聰Yun-Tsung Hung醫學研究所2026-10-299999-12-312019https://handle.ncl.edu.tw/11296/c6u29fhttps://scholars.csmu.edu.tw/handle/123456789/36477口腔癌在台灣一直是十大癌症之一,在台灣每10萬人口中約有33.16人得到口腔癌。因為其位置和功能的關係,口腔癌在切除後大多需要使用皮瓣重建。而為了提高游離皮瓣的存活率,重建科醫師在手術後時常會使用療血得注射液10% W/V (Rheomacrodex)。Rheomacrodex可以預防早期的血管栓塞,然而Rheomacrodex卻會損害患者的腎功能。我們統計了在彰化基督教醫院接受皮瓣修補手術的口腔癌病人,資料收集時間從2011/01 到2016/12。收錄的病人總共有427人,男性有407人,女性有20人。平均年齡為55.3歲,平均身體質量指數為23.1 (公斤/公尺2),平均血清肌酸酐指數為0.91(毫克/分升)。以邏輯回歸分析顯示,單變量與多變量分析中, 年齡、性別、是否使用Rheomacrodex、是否使用Prostaglandin E1 (PGE1)、是否術後進加護病房、是否為第一次開刀,其皮瓣成功率未具統計顯著意義;而身體質量指數、血清肌酸酐指數則有統計上的差別。抗凝血劑像是Rheomacrodex和PGE1通常會拿來預防血管的栓塞,但是它們同時也會增加病人出血的風險。在我們的研究發現,是否使用Rheomacrodex或是PGE1,在皮瓣的存活率並無統計上的差別。病人接受重建手術後,通常會在醫院住院2~4周。在我們研究裡,術後是否住進加護病房對於皮瓣的存活率並無統計上的差別。因此我們認為使用Rheomacrodex、使用PGE1和術後住進加護病房在前外側大腿皮瓣重建中不是必需的,特別是在那些低社經地位或是有許多慢性病的病患。Oral cavity cancer is one of the most common malignancies in Taiwan. Due to special location and function of the oral cavity, immediate reconstruction should be performed after complete excision of the tumor. In order to increase survial rate of flap, surgeon usually prescribed Rheomacrodex after operation. Rheomacrodex could prevent vessel thrombosis. However, Rheomacrodex will damage patient’s renal function. The data of this study are from those patient who received anterolateral thigh flap (ALT flap) reconstruction in Changhua Christian Hospital. Duration of data collection is from Jan. 2011 to Dec. 2016. Total Case number is 427, male is 407, female is 20. Mean age is 55.3. Mean BMI is 23.1 (kg/m2). Mean serum creatinine is 0.91 (mg/dl). In univariate and multivariate analysis, there are no statistical significance in Sex, age, the use of Rheomacrodex, the use of Prostaglandin E1 (PGE1), staying ICU after operation and first operation. However, BMI and serum creatine have statistical significance. Anticoagulants, such as Rheomacrodex and PGE1, are often used to prevent vessel thrombosis. However, patients are more likely to bleed. In our study, Rheomacrodex and PGE1 showed no statistical significance in flap survival. Patients who receive reconstruction surgery may stay in hospital for 2 ~4 weeks. In our study, we also found that no matter staying at ICU or not, there is no statistical significance in flap survival rate.We conclude that Rheomacrodex, PGE1 and staying at ICU are not necessary in ALT flap reconstruction, especially in those with low socioeconomic status or chronic disease patients.前外側大腿皮瓣抗凝血存活率加護病房anterolateral thigh flapanticoagulantsurvivalintensive care unit術後給予Rheomacrodex對於前外側大腿皮瓣的存活率影響thesis